Breast cancer has historically been a disease for which immunotherapy was largely unavailable. Recently. the use of immune checkpoint inhibitors (ICIs) in combination with chemotherapy for the treatment of advanced/metastatic triple-negative breast cancer (TNBC) has demonstrated efficacy. including longer progression-free survival and increased overall survival in subsets of patients. https://www.jmannino.com/amazing-price-Handlebar-for-Motovox-MBX10-and-MBX11-Mini-Bikes-amazing-deal/